Given the profound associations with distinct genomic alterations, ICOS is supposed to play a vital role in gliomagenesis, glioma progression, microenvironment remodeling, and drug resistance (49), further confirming its robust correlation with higher malignancy of gliomas. The gene discussed is ICOS; the disease is central nervous system cancer.